We support boolean queries, use +,-,<,>,~,* to alter the weighting of terms
We offer expanded tick testing services for a variety of tick-borne pathogens, including Babesia, Anaplasma, Rickettsia, Bartonella, and others.
THIS RESOURCE IS NO LONGER IN SERVICE. Documented on October 21,2025. An Portal, Core facility.
An Portal, Core facility
THIS RESOURCE IS NO LONGER IN SERVICE. Documented on April 15,2024. With broad and comprehensive capabilities, Waisman Biomanufacturing is uniquely situated and highly qualified to lead clients through the complex process of bringing a novel therapeutic into the clinic. Integral to any product campaign is a well thought-out product development plan. You can rely on our business manager and team of project leaders to work closely with you to maintain an on-going flow of communication and develop a time and cost effective plan that meets your needs. Utilizing our expertise in both Quality Assurance/Control and Process Development/Manufacture we can translate your bench top process to a large scale manufacturing process. Using this strategy Waisman routinely produces cGMP grade material qualified for clinical trials for a wide variety of applications.
Located at Beijing Economic and Technological Development Area, Beijing, China, was founded by former employees from Invitrogen/Biosource and BD PharMingen and researchers at US universities in September 2009. QuantoBio focuses on developing and manufacturing high quality reagents on the research on immunology, cell biology, cancer, inflammation and related diseases for the market in the World as well as China. The product portfolios include immunoassays, recombinant bioactive proteins, antibodies on various applications including flow cytometry, Western blotting and Immunohistochemistry, microRNA profiling and assay kits and other cutting-edge research reagents. The vigorous product development combines internal product development, technology licensing, and collaborations with research laboratories worldwide. With rich experience and knowledge in product development, we offer the ranges of custom services on immunoassay and antibody developments, recombinant protein expression and bioassays, microRNA profiling, microRNA overexpression and knock-down.
TG Labs Company, located in Colorado, has two divisions Technical division and Industrial division. Technical Division operates scientific, medical and chemical discovery laboratory in Englewood, Colorado. This division also develops special devices, equipment and processes for the medical, chemical and environmental industries. We offer proven solutions from concept through full scale production, including regulatory standards.
Genotype Calling and Copy Number Analysis tool for Affymetrix SNP 5.0 and 6.0 and Illumina arrays.
The ANFF provides leading-edge research capability and supports excellence in science. The capability provided by ANFF enables users to process hard materials (metals, composites and ceramics) and soft materials (polymers and polymer-biological moieties) and transform these into structures that have application in sensors, medical devices, nanophotonics and nanoelectronics. It has a strong emphasis on service provision to the research community. ANFF seeks to enhance national and international collaborations and enable world-class-research.
Vivalis contract manufacturing services offers a full suite of services that include GMP cell banking, GMP antibody production, and GMP virus production. Our manufacturing facility has been approved by the French Medicines Agency for GMP production up to Phase II clinical trials. A rigorous Quality Management System (QMS) maintains GMP compliance and further ensures adherence to these quality requirements.
Meridian Life Science is a leading manufacturer and supplier of antibodies, viral antigens and critical assay reagents. We provide contract biologic R&D and manufacturing services to the diagnostic manufacturers along with cGMP biologics manufacturing for the biopharmaceutical market. We have been providing innovative life science solutions and building trusted partnerships for over 25 years. Our focus is to offer products and services that help to advance the diagnosis and treatment of disease. Contract manufacturing of proteins and other biologicals for biopharmaceutical and biotechnology companies engaged in research for new drugs and vaccines is an example of significant new product applications built from Meridian Life Science''s existing expertise in manufacturing bulk antigens and reagents using cell culture techniques. This business focuses on cGMP contract manufacturing of materials that will be used in Phase I and II clinical trials.
Advanced BioScience Laboratories, Inc (ABL) is a leading contract research and manufacturing organization, partnering with our clients to advance their vaccine and therapeutic development programs. Our unique combination of preclinical and clinical services provide the tools to address the scientific challenges encountered during any stage of product development. For preclinical studies, we utilize immunological, molecular, and cell-based assay platforms for candidate selection. We offer proof-of-concept in vivo studies with preclinical immunomonitoring and efficacy and potency testing. Once a clinical candidate is identified, ABL''s in-house cGMP suites are designed for single-use technologies accommodating a wide range of products, including mammalian- and microbial-based protein therapeutics as well as viral vectors and vaccines.
An Portal, Core facility
THIS RESOURCE IS NO LONGER IN SERVICE. Documented on April 15,2024. A Contract research organization offering pre-clinical drug evaluation service specialising in models of cardiovascular and inflammatory diseases such as myocardial ischemia, haemorrhagic shock, endotoxaemia also inflammatory bowel disease (IBD), neutrophil migration, pulmonary fibrosis, systemic lupus erthematosus (SLE), adjuvant arthritis, collagen II arthritis, EAE and many more.
Delivering high quality immunohistochemical and immunofluorescent staining on cells and tissue sections, specialising in multi immunoflourescent colocalisation staining technologies. Equipped with three Vision Biosystems Bond staining robots Mike offers high throughput or custom antibody optimisation services. Time consuming multi colocalisation including same species primaries, are automated saving time and money. A large range of imaging platforms including three confocals, widefield, stereology, image analysis, digital photograpy and PALM laser capture microscopy are available. A full range of secondary antibodies and detection systems are available for purchase in ul quantities. There are currently 1900 antibodies recorded on our database.
THIS RESOURCE IS A DUPLICATE AND IS BEING REMOVED. A fee-for-service core facility that provides services and supervision in Transmission Electron Microscopy.
Metabolic Solutions provides comprehensive support services for researchers interested in using stable isotope tracers. Since 1990, nearly 1,000 investigators from around the world representing the pharmaceutical industry, government and academia have benefited from our services. Our experienced, accessible and responsive staff coupled with our GLP compliant mass spectrometry service ensures that your study goals are realized in a timely and cost effective manner. If you are interested in employing stable isotope techniques to measure glucose metabolism, assess total body water, determine free-living energy expenditure, monitor gastric motility, evaluate breath samples or utilize another tracer application, Metabolic Solutions can help!
The High Resolution Plant Phenomics Centre (HRPPC) is the Canberra node of the Australian Plant Phenomics Facility and is located in Canberra at CSIRO Plant Industry and the Australian National University. This centre focuses on _������_deep phenotyping_���� (delving into metabolism and physiological processes within the plant) and _������_reverse phenomics_���� (dissecting traits to discover their mechanistic basis). Next generation research tools are applied to probe plant function and performance, under controlled conditions and in the field. Recent advances in robotics, imaging and computing are used in applying these technologies and scaling them from the single plant to the ecosystem level. Two levels of service are provided in the HRPPC. First, projects can be housed in the _������_Research Hotel_���� environment where screening systems can be developed using facility staff and resources then deployed in the facility and in the user''''s home institution. Second, users_������_ material can be screened for specific attributes using one or more of the modules housed at CSIRO or the ANU. The HRPPC''''s focus is on flexibility from cereals to dicots and woody perennials at all stages of development.
Core develops and writes curriculum and interactive web-based materials in the following subjects: bioinformatics, genetics, molecular biology, microbiology, immunology Digital World Biology also offers on-site, hands-on, professional development workshops for college instructors and high school teachers.
AM Biotechnologies develops DNA-based affinity agents called thioaptamers using unique chemistries and a proprietary bead-based selection process. Antibodies are currently the most widely-used affinity agents but they are produced in animals; are easily degraded; are expensive to produce; and suffer from batch-to-batch variability. In contrast, thioaptamers are chemically synthesized; they are stable in ambient environments with very long shelf life; and are rapidly produced in large quantities with easy quality control. We solve the problems associated with antibodies while delivering the same functionality. Thioaptamers can be substituted for antibodies in virtually any application. We can develop thioaptamer affinity agents for your targets using our bead-based development service. AM also offers DNA thiophosphoramidite reagents via a strategic partnership with Glen Research Corporation and the RNA thiophosphoramidites are near market introduction. These unique reagents are used to synthesize thioaptamers and are also highly useful for providing in vivo stability and increased potency in RNAi applications. The company was founded in 2006 and is primarily owned by two corporations. It has been awarded numerous SBIR grants and has also benefited from over $10M of prior university research into its technologies. Importantly, all of our technologies have freedom to operate.
Provides oligonucleotides. Synthesizes custom DNA/RNA oligonucleotides for scientific and therapeutic communities.